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Abstract
Background:  Cryotherapy (the application of ice for therapeutic purposes) is one of the most common
treatment modalities employed in the immediate management of acute soft tissue injury. Despite its widespread
clinical use, the precise physiological responses to therapeutic cooling have not been fully elucidated, and effective
evidence-based treatment protocols are yet to be established. Intermittent ice applications are thought to exert
a significant analgesic effect. This could facilitate earlier therapeutic exercise after injury, potentially allowing for
a quicker return to activity. The primary aim of the forthcoming study is therefore to examine the safety and
effectiveness of combining intermittent ice applications with periods of therapeutic exercise in the first week after
an acute ankle sprain.
Methods/Design: The study is a randomised controlled trial. 120 subjects with an acute grade I or grade II ankle
sprain will be recruited from Accident & Emergency and a University based Sports Injury Clinic. Subjects will be
randomised under strict double-blind conditions to either a standard cryotherapy (intermittent ice applications
with compression) or cryokinetic treatment group (intermittent ice applications with compression and
therapeutic exercise). After the first week, treatment will be standardised across groups. Assessor blinding will
be maintained throughout the trial. Primary outcome will be function, assessed using the Lower Extremity
Functional Scale (LEFS). Additional outcomes will include pain (10 cm Visual Analogue Scale), swelling (modified
figure-of-eight method) and activity levels (activPAL™ physical activity monitor, PAL Technologies, Glasgow, UK).
Diagnostic Ultrasound (Episcan-1-200 high frequency ultrasound scanning system, Longport International Ltd, PA)
will also be used to assess the degree of soft tissue injury. After baseline assessment subjects will be followed up
at 1, 2, 3 & 4 weeks post injury. All data will be analysed using repeated measures analysis of co-variance
(ANCOVA).
Discussion: This paper describes the rationale and design of a randomised controlled trial which will examine
the effectiveness of two different cryotherapy protocols in the early management of acute ankle sprain.
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Background
Ankle injuries represent one of the most commonly occur-
ring musculoskeletal complaints. The vast majority of
such injuries occur as a result of inversion trauma with the
foot in some degree of plantar flexion and involve damage
to the lateral structures of the ankle. Sprains of the lateral
ankle ligaments are associated with significant costs [1]
and account for an estimated 302,000 annual admissions
to Accident & Emergency (A&E) Departments in the UK
[2].
In addition to the immediate onset of pain, swelling and
loss of joint motion, it has been reported that in 15 – 73%
of cases, chronic ankle instability (CAI) with recurrent
sprains and residual sensations of giving way may occur
following lateral ankle sprain [3,4]. However, the precise
etiology of CAI is unclear and as a consequence the opti-
mal intervention for the management of acute ankle
sprain is controversial. While a significant body of evi-
dence supports the use of early functional treatment [5-7],
there is little high quality research evidence to suggest
which interventions best augment this treatment
approach. Clinicians therefore continue to treat such inju-
ries pragmatically, with current recommendations ranging
from no intervention to physiotherapy referral, prophy-
lactic bracing, or cast immobilisation [8-11].
Cryotherapy (the application of ice for therapeutic pur-
poses) is a common treatment modality employed in the
management of acute soft tissue injuries. Despite its wide-
spread clinical use, the precise physiological responses to
ice application have not been fully elucidated. Moreover,
the rationale for its use at different stages of recovery is
quite distinct. In the acute inflammatory phase after soft
tissue injury, cryotherapy is thought to decrease oedema
formation via induced vasoconstriction, and reduce sec-
ondary hypoxic damage by lowering the metabolic
demand of injured tissues [12,13]. Cooling skin surface
temperature to below approximately 15°C is also thought
to exert a localised analgesic effect by inhibiting nerve
conduction velocity [14,15]. Short periods of ice applica-
tion have been used during the later, sub-acute phase of
inflammation to produce a similar analgesic effect, thus
facilitating earlier and more aggressive therapeutic exer-
cise after muscle injury [16,17]. This combined use of cry-
otherapy and exercise has previously been termed
cryokinetics [18]. Recent evidence has suggested that the
addition of exercise to ice application is more effective
than ice application alone after various soft tissue injuries,
including acute ankle sprain [19]. However, by reducing
the conduction velocity of other, non-nociceptive fibres,
cold application may also have a number of deleterious
effects, including reduced muscle torque [20]. This is of
particular relevance if ice is to be applied in combination
with therapeutic exercise in the early stages after an acute
soft tissue injury. Such effects could lead to the develop-
ment of altered neuromuscular control patterns and
potentially, to an increased risk of re-injury. Conversely,
other evidence has shown that ice application does not
negatively affect myotatic reflex activity [21], joint posi-
tion sense [22], plantar flexion torque [23] or more func-
tional measures of agility [24,25]. Such conflicting
findings may relate to the marked variation in cryotherapy
protocols described in the literature, particularly in rela-
tion to the site, mode and duration of ice application.
These factors, in addition to the level of subcutaneous fat,
dictate the degree of superficial and deep tissue cooling,
and therefore have a direct effect on the subsequent phys-
iological response to cryotherapy [26].
Evidence from a large-scale systematic review suggested
that intermittent ice applications of 10 minutes are most
effective at reducing tissue temperature in both injured
animal and healthy human models [27]. Such ice applica-
tions have been shown to reduce skin temperature to 5°C
immediately after treatment [28]. A recent study by our
research group also found that intermittent ice applica-
tions are more effective than continuous ice at reducing
pain on activity after ankle sprain [29].
Given these findings, it seems a logical progression to
examine if the analgesic effects of intermittent ice applica-
tion can facilitate earlier therapeutic exercise, and subse-
quently improve clinical outcome following acute ankle
sprain. The safety and effectiveness of incorporating ther-
apeutic exercise with periods of intermittent ice applica-
tion has not previously been examined in patients with
acute soft tissue injury. The primary aim of the forthcom-
ing trial is therefore to compare the effectiveness of stand-
ard intermittent versus cryokinetic ice applications in the
management of acute grade I and grade II ankle sprains. In
this manner we hope to contribute further to the existing
evidence base in the area of acute soft tissue injury man-
agement.
Methods/Design
The study is a randomised controlled trial (RCT). Figure 1
shows a brief summary of the trial design. The primary
trial site will be the A&E Department of the Royal Victoria
Hospital, Belfast, Northern Ireland. Subjects will also be
recruited from the Sports Injury Clinic at the University of
Ulster, Jordanstown, Northern Ireland. Following guide-
lines set out in the CONSORT statement [30], the number
of patients assessed, randomised to treatment groups,
who complete the study and who are included in the final
analysis of the primary outcome shall be recorded during
the trial. This will enable a participant flow diagram to be
constructed. Ethical approval for the trial has been
granted by The University of Ulster Research Ethics Com-
mittee [National Research Ethics Service referenceBMC Musculoskeletal Disorders 2007, 8:125 http://www.biomedcentral.com/1471-2474/8/125
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number: 06/NIR03/148]. All patients who agree to take
part will be required to give informed written consent
prior to participation in the study.
Study population
All patients between 16–65 years with an acute lateral
ankle sprain (less than 1 week since injury) will be consid-
ered for participation in the study.
Identification of potential subjects
Following initial assessment by an attending clinician
(Emergency Nurse Practitioner, Physiotherapist or Doc-
tor) patients with a suspected ankle sprain will be
approached by a member of the research team and given
a brief verbal explanation of the study. They will then be
provided with a detailed study information sheet to con-
sider while awaiting routine x-ray. This will allow for a
standard 'cooling off' period of at least 1 hour.
Inclusion/exclusion criteria
Patients with an acute grade I or grade II sprain will be
included in the trial on the basis of a standard physical
examination of the acutely injured ankle. As part of this
assessment, the following demographic information will
be recorded: date of birth, height, mass, gender, limb
dominance and occupation. Activity level prior to injury
will also be recorded and used to group patients according
to whether they are from an athletic (defined as participat-
ing in high-intensity exercise for more than 90 minutes at
least 3 times per week) or non-athletic population.
Patients will be excluded if any of the following criteria are
present: Complete (Grade III) ankle ligament rupture
(mechanical instability diagnosed by a positive anterior
drawer or inversion stress test); Bony ankle injury (indi-
cated by Ottawa ankle rules [31] or plain x-ray); Multiple
injuries (e.g. other joint injury or fracture); Ankle sprain
more than 1 week since injury; Any contraindication to
cryotherapy including cryoglobinaemia, peripheral vascu-
lar disease or Raynaud's syndrome. Subjects will also be
excluded if they are non-English speaking, have any con-
dition which will affect understanding and communica-
tion, are under the influence of drugs/alcohol, or if there
is no sufficient address given for follow-up.
Baseline outcome measurements
Baseline recording of all outcome measures shall be car-
ried out by the same researcher prior to randomisation.
Primary outcome measure
i) Subjective ankle function, assessed using the Lower
Extremity Functional Scale (LEFS) [32]. The LEFS is an 80
point scale which has been shown to have excellent test-
retest reliability (intraclass correlation coefficient [ICC] =
0.94, 95% confidence interval [CI] lower limit = 0.89).
The scale has a potential error of ± 5.3 points (90% CI),
with a minimal detectable change (MDC) and minimal
clinically important difference (MICD) of 9 points (both
90% CI).
Secondary outcome measures
ii) Pain assessed using a 10 cm visual analogue scale,
marked "no pain" at one end and "worst pain imagina-
ble" at the other. This form of assessment is considered
most appropriate because of its high level of repeatability
when used serially on the same patient [33].
iii) Swelling assessed using a modified version of the fig-
ure-of-eight method [34]. High intra and inter-rater relia-
bility has been reported using this technique (ICC = 0.99,
95% CI lower limit = 0.98), MDC = 9.6 mm (95% CI). To
determine the degree of swelling, the mean value (of 2
measures) will be subtracted from the mean value of the
uninjured ankle.
iv) Physical activity levels assessed using the activPAL™
professional physical activity logger (PAL technologies,
Summary of trial design Figure 1
Summary of trial design.
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Glasgow, UK). Reported ICCs for inter-device reliability
range from 0.79–0.97 (CIs not stated) [35]. The activPAL™
unit (5 cm × 3 cm) will be worn on the thigh of the injured
leg, for one week post injury. Time spent sitting, standing
and walking under free living conditions will be com-
pared between groups.
Tertiary outcome measure
v) Diagnostic ultrasound scanning (Episcan-1-200 high
frequency ultrasound scanning system, Longport Interna-
tional Ltd, PA) will be used to examine the lateral struc-
tures of the injured and uninjured ankle. Images will be
used to quantify the degree of soft tissue swelling and
identify the relative positions of the fibula and talus (Fig-
ure 2). It is anticipated that this will provide a more accu-
rate measure of swelling, and provide a useful tool to
guide future clinical studies. For practical reasons, only
those subjects who are recruited through the University
Sports Injury Clinic will undergo ultrasound scanning.
Treatment allocation
A statistician who will have no contact with the day to day
running of the trial shall carry out all aspects of prepara-
tion for group randomisation. 184 randomisation enve-
lopes will be produced in the following manner: 92 cards
will be printed with Group I (standard ice application).
92 cards will be printed with Group II (cryokinetic ice
application). Each card will be placed inside an opaque
envelope with carbon paper on top. A randomisation
sequence will then be generated using computer software.
Stratified randomisation will be employed according to
whether subjects are from an athletic (A) or non-athletic
population (N). Separate block randomisation sequences
will be produced for each stratum using an allocation
ratio of 1:1 and a block size of 4 to ensure comparison
groups are of approximate size. Envelopes for each stra-
tum will be labeled sequentially (1A-92A & 1N-92N).
Envelopes will then be sealed and signed across the seal.
Following baseline assessment, these instructions, in
sequentially numbered opaque sealed envelopes, will be
used to assign sequentially enrolled subjects to one of the
two treatment groups. Subjects shall therefore be ran-
domised to treatment groups under strictly double-blind
conditions. Before opening the envelope, the Research
Physiotherapist will write the subjects unique identifica-
tion number (stratification number & date of birth) on
the outside of the envelope, transferring this information
to the instruction card. At the end of the trial this will
allow the Principle Investigator to check each card against
the original randomisation lists and verify that all subjects
received the treatment to which they were assigned.
Treatment protocols
All subjects will receive an initial treatment, administered
by the same Research Physiotherapist, in A&E or the Uni-
versity Sports Injury Clinic. Standard treatment (Group I)
will consist of intermittent ice and compression only.
Subjects will receive a 10 minute ice application. The ice
pack will then be removed for 10 minutes before a further
10 minute ice application. This will then be followed by a
further 10 minutes of rest (10 minutes ice/10 minutes
rest/10 minutes ice/10 minutes rest). Cryokinetic treat-
Ultrasound images of lateral ankle Figure 2
Ultrasound images of lateral ankle. (a) Un-injured control. (b) Grade I sprain 7 days post injury. The hypoechoic zone between 
the markers (*) indicates an area of soft tissue swelling. F = Fibula. T = Talus. ATFL = Anterior talofibular ligament. [Scale = 
mm]BMC Musculoskeletal Disorders 2007, 8:125 http://www.biomedcentral.com/1471-2474/8/125
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ment (Group II) will consist of intermittent ice and com-
pression with therapeutic exercise. Subjects will receive a
10 minute ice application. The ice pack will then be
removed and the subject will perform 10 minutes of ther-
apeutic exercise. This will be followed by another 10
minute ice application and a further 10 minutes of thera-
peutic exercise (10 minutes ice/10 minutes exercise/10
minutes ice/10 minutes exercise). Subjects will be respon-
sible for ice pack preparation and self administering sub-
sequent treatments at home (3 times per day for the first
week after injury). Compliance with treatment and anal-
gesic consumption will be monitored by the use of a treat-
ment diary. Standard advice regarding general
mobilisation exercises and weight bearing will also be
given to both groups according to routine A&E practice.
Cryotherapy
Mode of cryotherapy will be standardised across groups
(melting iced water [0°C] in a standard sized pack). Clear
plastic commercial ice cube bags (17 cm × 28 cm) will be
completely filled with water and frozen. Before applica-
tion, ice packs will be held under hot running water for 30
seconds and wrapped in a single layer of towelling (mois-
tened until just dripping wet). The packs will then be
placed over the lateral aspect of the ankle joint, covering
an area from the Achilles tendon to the anterior tibialis
muscle, with the approximate center of the pack overlying
the anterior talofibular ligament (ATFL). Compression
will be applied over the pack using 8 cm cohesive bandag-
ing with approximately 5–6 cm of stretch (Figure 3). Tim-
ing of the cryotherapy protocol will begin as soon as the
compression bandage is in place. A standard verbal expla-
nation and step by step written instructions of the correct
procedure for ice pack preparation and application will be
given. All necessary equipment will be provided.
Exercise
Subjects in group II will be provided with verbal and writ-
ten instructions, and a DVD demonstrating each of the
additional exercises. The exercise component (Table 1)
has been adapted from a standard written protocol [36]
and is designed to take approximatly 10 minutes to com-
plete.
Follow-up procedure & blinding
At week 1 post injury, function, pain and swelling (out-
come measures i, ii, and iii) will be re-assessed by the
same researcher who shall remain blinded to group allo-
cation throughout the trial. The activity monitor will also
be removed for data collection at this stage (outcome
measure iv). Subjects will hand their treatment diaries to
the Research Physiotherapist who will re-assess the
injured ankle. Follow-up ultrasound images (outcome
measure v) shall be taken in those subjects recruited
through the University Sports Injury Clinic. After week 1,
individual treatment will be progressed in both groups
according to clinical need, but will follow a standarised
protocol consisting of early, intermediate and advanced
stage muscle strengthening, proprioceptive and functional
exercises. Subsequent follow-ups shall take place at weeks
2, 3 and 4. Researcher blinding is described in Table 2.
Additional follow up study
In a sub-section to the main trial, longer term function
and ankle muscle strength will be examined in a sample
of study subjects at 3 months post-injury. While chronic
instability and recurrent injuries are a frequent complica-
tion following an initial sprain, the precise reasons why
such injuries tend to reoccur are unclear at present, and as
a consequence rehabilitation may be problematic. It has
been suggested that specific evertor muscle strength defi-
cits might be a significant factor in the pathogenesis of
CAI [37,38]. However, other evidence does not support
this contention [39,40]. Previous research has examined
conventional eccentric to concentric ratios of individual
muscle groups, or concentric evertor to invertor ratios [39-
42]. Since dynamic joint stabilization is achieved by co-
contraction of the muscles surrounding the joint, it might
Table 1: Therapeutic exercises for treatment group II
Exercise Repetitions Time (Sec)
Circumduction (clockwise/
anticlockwise)
20 60
Active pf/df 20 60
Static ev/in/pf/df (with 10 second 
hold)
5 of each 300
Heel slides (with lower limb triple 
extension)
30 120
Static calf stretch (with 30 second 
hold)
36 0
pf = plantar flexion. df = dorsi flexion. ev = eversion. in = inversion.
Method of ice pack application Figure 3
Method of ice pack application.BMC Musculoskeletal Disorders 2007, 8:125 http://www.biomedcentral.com/1471-2474/8/125
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be more appropriate to divide the eccentric moment of
the antagonist by the concentric moment of the agonist
[43]. Examination of such dynamic, reciprocal muscle-
group ratios represents an alternative approach to the
assessment of muscle strength deficits and imbalance fol-
lowing ankle sprain [44]. Here, muscle strength will be
assessed using a KinCom 500H isokinetic dynamometer
(Chattecx Corp., Hixson, TN). Isokinetic dynamometers
provide an accommodating resistance throughout full
range of motion, and have been shown to provide a safe
and reliable measure of ankle strength [45]. Eccentric and
concentric peak torque values for eversion, inversion,
plantar flexion and dorsi flexion will be recorded at a
velocity of 60° sec-1. Raw data will be normalised for body
weight before dynamic ratios are calculated and compared
to the un-injured (control) ankle. For example, the eccen-
tric eversion to concentric inversion (eE/cI) ratio for a sub-
ject with a body weight (BW) of 88 kg is calculated in the
following way: If eE = 81 Newton metres (N.m) (eE/BW =
0.92 N.m/kg) and cI = 92 N.m (cI/BW = 1.15 N.m/Kg), the
eE/cI ratio would therefore be 0.92/1.15 = 0.80.
Sample size
Using data from a previous published study [32] an
appropriate sample size for the main trial has been deter-
mined using the formula shown in Figure 4[46]. Based on
a clinically meaningful difference for the primary out-
come measure of 9 points, and allowing for a 10% attri-
tion rate, a minimum number of 60 subjects will be
required for each treatment group (assuming 80% power
and a 0.05 alpha value).
Using the same formula, a sample size calculation has also
been carried out to determine the number of subjects
required in the 3 month follow up study. This calculation
is based on published data [47] and a clinically meaning-
ful difference between ankle muscle strength ratios of
approximately 30%. 30 subjects will be required with the
un-injured ankle acting as the control.
Statistical analysis
Analysis will be on an intention to treat basis. Data will be
analysed using SPSS (Windows Version 14.0). Assuming
data is from a normal distribution, descriptive statistics
will be performed to produce standard deviations (SD),
standard errors of the mean (SEM) and 95% confidence
intervals (CI). For all outcome measures, a within subject
repeated measures analysis of covariance (ANCOVA) will
be calculated to determine significant changes over time
between groups. Treatment group (two levels: standard
and cryokinetic ice application) will be the between sub-
jects factor. Time (four levels: week 1, 2, 3 & 4) will be the
within subject factor, with baseline values (week 0) used
as the covariate. Where Mauchley's test reveals the
assumption of sphericity had been violated the Green-
house-Geisser epsilon procedure will be carried out to
adjust the degrees of freedom accordingly. For all analysis
Tukey's test will be used to make post hoc adjustments for
multiple comparisons. If any significant interactions are
detected between treatment group and time point, a uni-
variate analysis of covariance will be used to indicate the
time point at which significant differences are found. If
Formula used for sample size calculations Figure 4
Formula used for sample size calculations.
Table 2: Blinding of each researcher during trial.
Researcher Role Blinding status
RP1 Recruitment, assessment, 
randomisation and treatment
Unblinded
BA All baseline and follow-up 
recording of function, pain, 
swelling and activity levels 
(outcome measures i, ii, iii, iv)
Blinded to group 
allocation
RP2 US images 
(outcome measure v)
Blinded to group 
allocation
IR Interpretation of US images 
(outcome measure v)
Blinded to group 
allocation
RP = Research Physiotherapist. BA = Blinded Assessor. US = 
Ultrasound. IR = Independent Researcher.BMC Musculoskeletal Disorders 2007, 8:125 http://www.biomedcentral.com/1471-2474/8/125
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required, analyses will be undertaken using the expecta-
tion maximisation algorithm method to impute missing
values [48]. A number needed to treat (NNT) analysis will
also be carried out. For the 3 month follow-up study, a 2
× 2 ANOVA will be calculated to determine if any signifi-
cant differences exist between isokinetic ratios of subjects
injured and un-injured (control) ankles. The level of sig-
nificance for all tests will be set at p < 0.05.
Discussion
Here we have described the rationale and design of a ran-
domised controlled trial comparing standard intermittent
versus cryokintic ice applications in the early management
of acute grade I and grade II ankle sprain. Although such
injuries are often regarded as being fairly innocuous,
recurrent sprains and sensations of instability are a fre-
quent sequelae of lateral ankle sprain. Perhaps this is not
surprising, given the complexity of the ankle joint and the
uncertainty regarding the precise aetiology of chronic
ankle instability. However, it may be that current treat-
ment recommendations are insufficient. More intensive
initial treatment and advice on potential complications
may help to reduce the incidence and associated costs of
long-term symptoms after an initial sprain. Intermittent,
ten minute periods of ice application and therapeutic
exercise in the early stages after injury may represent a
simple and cost effective intervention for both athletic
and non-athletic populations. However, high quality ran-
domised controlled trials are first required in order to
examine the effectiveness of such interventions.
The difficulties of conducting research in an acute setting
have previously been highlighted [49]. The process of
ensuring all potential patients are assessed for study eligi-
bility will be aided by the researchers being based in A&E
on a day to day basis, by working closely with Emergency
Nurse Practitioners responsible for triage assessment, and
by providing regular trial updates for other relevant clini-
cal staff. Trial profile shall be maintained by placing post-
ers in A&E and by regularly updating media sources
including the Hospital and University intranet.
Recruitment will begin in July 2007 and it is anticipated
that all data collection will be completed by July 2008.
Results of the trial will be disseminated through publica-
tion in relevant peer-reviewed journals and conference
proceedings.
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